AFT Pharmaceuticals

[lorraina]

My shares seem to go in cycles.
Just when I have my doubts they come right.
Then when I start to think I am clever, the market turns round and kicks me in the back side,and says you are still a dummy..lol.

[Basil]

Average price of more recognised analysts on Market screener is $4.65.

[lorraina]

I see research from Forbar and Craigs.Neither have covered AFT.
The latest research as far as I know is Pitt Street's.
I have already posted that Pitt Street's research is often suspect,although they got it 100% right on ATP.Atlas Pearls.
What I like about AFT.
It is in the medical sector.[Good margins]
Has a big market presence in both Australia and NZ.
Future growth is world wide.
Means I can buy a NZ listed company with growing overseas earnings.
Its products are excellent,
Its products are well presented in chemist shops.Very good bold displays.
Sales momentum is building rapidly.
Leader driven.
The business is profitable and pays a dividend.
The business is very scalable.
Current PE ratio of 30.30 may be modest for a company with such potential.

[Minimoke]

I see research from Forbar and Craigs.Neither have covered AFT.
The latest research as far as I know is Pitt Street's.
I have already posted that Pitt Street's research is often suspect,although they got it 100% right on ATP.Atlas Pearls.
What I like about AFT.
It is in the medical sector.[Good margins]
Has a big market presence in both Australia and NZ.
Future growth is world wide.
Means I can buy a NZ listed company with growing overseas earnings.
Its products are excellent,
Its products are well presented in chemist shops.Very good bold displays.
Sales momentum is building rapidly.
Leader driven.
The business is profitable and pays a dividend.
The business is very scalable.
Current PE ratio of 30.30 may be modest for a company with such potential.

The biggest problem I have is Hartly Atkinson owns 69%

[Left Field]

Crilkey..... lots of updates lately

https://www.nzx.com/announcements/476766

AFT R&D Portfolio Offers Multi-$bn Market Potential